SCHEMBL24475569

SCHEMBL24475569

c1cc(-c2ccc3ccc(-c4ccc5ccc(-c6ccc(-c7ccc8ccc9cccnc9c8n7)c7ccccc67)nc5c4)cc3n2)c2cnccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 3/20 0.45
MAPK10 P53779 1/20 0.38
CYP11B1 P15538 2/20 0.37
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B2 P19099 1/20 0.37
HTR2C P28335 2/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
RAB9A P51151 3/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP3A4 P08684 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475371 0.96 TNF (0.41) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL24475568 0.95 TNF (0.42) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL22281881 0.94 TNF (0.43) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL23016293 0.92 TNF (0.44) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL24475517 0.91 TNF (0.39) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL24475763 0.91 KDM4E (0.41) HTR2CKDM4EMAPTALDH1A1HPGD
SCHEMBL22282120 0.90 TNF (0.40) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL24475592 0.89 TNF (0.39) TNFMAPK10CYP11B1CYP17A1CYP19A1
SCHEMBL22281859 0.88 CCR1 (0.41) HTR2CKDM4EMAPTRAB9AHTT
SCHEMBL24475544 0.87 CYP11B1 (0.46) CYP11B1CYP17A1CYP19A1CYP11B2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 TNF 4042/4885MAPK10 467/4885CYP11B1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.